Archive for April, 2010
« Previous EntriesProstate cancer vaccine ready
Friday, April 30th, 2010The US government has given its nod to the world’s first cancer vaccine that treats prostate cancer after it has been diagnosed, helping the patient live a little longer. Sanchita Sharma reports. How it works
Provenge Approved for Advanced Prostate Cancer
Friday, April 30th, 2010Title: Provenge Approved for Advanced Prostate Cancer Category: Health News Created: 4/29/2010 2:10:00 PM Last Editorial Review: 4/30/2010
FDA OKs prostate cancer vaccine
Friday, April 30th, 2010NEW YORK TIMES WASHINGTON - The Food and Drug Administration yesterday approved the first treatment that uses a so-called cancer vaccine, a drug that trains the body’s own immune system to fight the disease. The drug, Provenge, developed by the Dendreon Corp., was approved to treat advanced prostate cancer. In clinical trials it extended the lives of patients about four months compared with a …
FDA approves $93K prostate cancer vaccine
Friday, April 30th, 2010The Food and Drug Administration today approved the first vaccine to treat prostate cancer or any cancer the culmination of decades of research into harnessing the immune system to fight tumors.
Prostate cancer vaccine approved
Friday, April 30th, 2010A “vaccine” which uses the body’s immune system to fight prostate cancer is approved for use by US drug regulators.
FDA OKs drug to help fight prostate cancer
Friday, April 30th, 2010A cancer vaccine that stimulates the immune system to fight advanced prostate cancer was approved Thursday by the Food and Drug Administration , the first time a therapy of this kind has been approved to treat cancer. The vaccine, Provenge, isn’t a cure for cancer. And it doesn’t prevent men from getting prostate cancer. But Provenge does appear to modestly prolong survival in men whose cancer …
Approval Of Prostate Cancer Immunotherapy Marks Milestone In New Era Of Cancer Treatments
Friday, April 30th, 2010Today’s announcement that the U.S. Food and Drug Administration has approved Provengeâ, a new form of therapy for some prostate cancer patients, marks the beginning of an era in which patients’ own immune systems become part of the standard therapeutic arsenal against cancer, say Dana-Farber Cancer Institute investigators who led a study of the treatment’s effectiveness in patients…
FDA Approves PROVENGE For The Treatment Of Men With Advanced Prostate Cancer
Friday, April 30th, 2010Dendreon Corporation (Nasdaq: DNDN ) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).
FDA OKs drug to help fight prostate cancer
Friday, April 30th, 2010A cancer vaccine that stimulates the immune system to fight advanced prostate cancer was approved Thursday by the Food and Drug Administration , the first time a therapy of this kind has been approved to treat cancer. The vaccine, Provenge, isn’t a cure for cancer. And it doesn’t prevent men from getting prostate cancer. But Provenge does appear to modestly prolong survival in men whose cancer …
WATCH: FDA Approves Prostate Cancer Vaccine
Friday, April 30th, 2010The medical community reacts to groundbreaking news. Food and Drug Administration - Cancer - Health - Conditions and Diseases - Prostate
« Previous Entries